Purpose The identification of a molecular signature predicting the relapse of tamoxifen treated primary breast cancers should help the therapeutic management of estrogen receptor positive cancers azithromycin vs doxycycline Nevertheless, the influence on survival and adverse effects should be further investigated in a phase 3 trial